Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Statements of Cash Flows (Detail)

v2.4.0.8
Condensed Consolidating Statements of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Operating Activities    
Net cash provided by (used in) operating activities $ 36,883 $ 40,323
Investing Activities    
Proceeds from sale of property, plant and equipment 2,008 1,177
Proceeds (loss) on sale of businesses, net of transaction costs 243,386  
Intercompany investment 0  
Capital expenditures (22,226) (11,726)
Business acquisitions, net of cash acquired 0 (83)
Net cash provided by (used in) investing activities 223,168 (10,632)
Financing Activities    
Net repayments on revolver (125,000) 0
Principal repayments on term loan 0 (2,500)
Intercompany loan activity   0
Changes in receivables and payables to subsidiaries 0  
Intercompany capital contributions 0  
Purchase of treasury shares (109,095) (8,821)
Stock option exercises and related tax benefits 25,803 10,772
Payment of contingent acquisition consideration (753) (1,350)
Cash dividend (2,919) (2,911)
Net cash used in financing activities (211,964) (4,810)
Effect of exchange rate changes on cash 2,944 (2,242)
Net increase (decrease) in cash and cash equivalents 51,031 22,639
Cash and cash equivalents – beginning of period 103,986 68,184
Cash and cash equivalents – end of period 155,017 90,823
Parent
    
Operating Activities    
Net cash provided by (used in) operating activities (223) 5,606
Investing Activities    
Proceeds from sale of property, plant and equipment 1 562
Proceeds (loss) on sale of businesses, net of transaction costs (4,134)  
Intercompany investment 0  
Capital expenditures (2,424) (668)
Business acquisitions, net of cash acquired   0
Net cash provided by (used in) investing activities (6,557) (106)
Financing Activities    
Net repayments on revolver (125,000)  
Principal repayments on term loan   (2,500)
Intercompany loan activity   (7,370)
Changes in receivables and payables to subsidiaries 213,449  
Intercompany capital contributions 0  
Purchase of treasury shares (109,095) (8,821)
Stock option exercises and related tax benefits 25,803 10,772
Payment of contingent acquisition consideration 0 (1,350)
Cash dividend (2,919) (2,911)
Net cash used in financing activities 2,238 (12,180)
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents (4,542) (6,680)
Cash and cash equivalents – beginning of period 16,122 12,401
Cash and cash equivalents – end of period 11,580 5,721
Guarantors
    
Operating Activities    
Net cash provided by (used in) operating activities 8,331 8,913
Investing Activities    
Proceeds from sale of property, plant and equipment 74 74
Proceeds (loss) on sale of businesses, net of transaction costs 214,268  
Intercompany investment (99,963)  
Capital expenditures (2,379) (2,014)
Business acquisitions, net of cash acquired   0
Net cash provided by (used in) investing activities 112,000 (1,940)
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity   (7,064)
Changes in receivables and payables to subsidiaries (120,305)  
Intercompany capital contributions 0  
Purchase of treasury shares 0 0
Stock option exercises and related tax benefits 0 0
Payment of contingent acquisition consideration 0 0
Cash dividend 0 0
Net cash used in financing activities (120,305) (7,064)
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 26 (91)
Cash and cash equivalents – beginning of period 0 91
Cash and cash equivalents – end of period 26 0
Non-Guarantors
    
Operating Activities    
Net cash provided by (used in) operating activities 43,491 25,804
Investing Activities    
Proceeds from sale of property, plant and equipment 1,933 541
Proceeds (loss) on sale of businesses, net of transaction costs 33,252  
Intercompany investment 0  
Capital expenditures (17,423) (9,044)
Business acquisitions, net of cash acquired   (83)
Net cash provided by (used in) investing activities 17,762 (8,586)
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity   14,434
Changes in receivables and payables to subsidiaries (93,144)  
Intercompany capital contributions 99,963  
Purchase of treasury shares 0 0
Stock option exercises and related tax benefits 0 0
Payment of contingent acquisition consideration (753) 0
Cash dividend (14,716) 0
Net cash used in financing activities (8,650) 14,434
Effect of exchange rate changes on cash 2,944 (2,242)
Net increase (decrease) in cash and cash equivalents 55,547 29,410
Cash and cash equivalents – beginning of period 87,864 55,692
Cash and cash equivalents – end of period 143,411 85,102
Eliminations
    
Operating Activities    
Net cash provided by (used in) operating activities (14,716) 0
Investing Activities    
Proceeds from sale of property, plant and equipment 0 0
Proceeds (loss) on sale of businesses, net of transaction costs 0  
Intercompany investment 99,963  
Capital expenditures 0 0
Business acquisitions, net of cash acquired   0
Net cash provided by (used in) investing activities 99,963 0
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity   0
Changes in receivables and payables to subsidiaries 0  
Intercompany capital contributions (99,963)  
Purchase of treasury shares 0 0
Stock option exercises and related tax benefits 0 0
Payment of contingent acquisition consideration 0 0
Cash dividend 14,716 0
Net cash used in financing activities (85,247) 0
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents – beginning of period 0 0
Cash and cash equivalents – end of period $ 0 $ 0